RISPERDAL 37,5 MG PO INJ IM CT FA VD TRANS + DIL SER VD TRANS X 2 ML + 2 AGU + 1 ADAPT
Presentation · Câmara de Regulação do Mercado de Medicamentos (CMED), Secretaria Executiva exercida pela Agência Nacional de Vigilância Sanitária (ANVISA) · Brazil
-
Registration number
1123600310400 -
GGREM
514518050034603 -
Barcode
7896212425587
What the source publishes
- Holder
- JANSSEN-CILAG FARMACEUTICA LTDA
- Active ingredients
- RISPERIDONA
- Package
- 37,5 MG PO INJ IM CT FA VD TRANS + DIL SER VD TRANS X 2 ML + 2 AGU + 1 ADAPT
- Supply regime
- Tarja Vermelha sob restrição
- Product type
- Novo
- Therapeutic class
- N5A1 - ANTIPSICÓTICOS ATÍPICOS
- Prescription
- Prescription or restricted
Names this record is found by
- RISPERDAL 37,5 MG PO INJ IM CT FA VD TRANS + DIL SER VD TRANS X 2 ML + 2 AGU + 1 ADAPT
- RISPERDAL
- RISPERIDONA
Complete source data
{
"name": "RISPERDAL 37,5 MG PO INJ IM CT FA VD TRANS + DIL SER VD TRANS X 2 ML + 2 AGU + 1 ADAPT",
"holder": "JANSSEN-CILAG FARMACEUTICA LTDA",
"stripe": "Tarja Vermelha sob restrição",
"barcodes": [
"7896212425587"
],
"confaz87": false,
"currency": "BRL",
"marketed": null,
"ggremCode": "514518050034603",
"useDomain": "unknown",
"capApplies": null,
"icmsExempt": false,
"holderTaxId": "51.780.468/0001-87",
"priceRegime": "Regulado",
"productName": "RISPERDAL",
"productType": "Novo",
"hospitalOnly": false,
"presentation": "37,5 MG PO INJ IM CT FA VD TRANS + DIL SER VD TRANS X 2 ML + 2 AGU + 1 ADAPT",
"sourceStatus": null,
"supplyRegime": "Tarja Vermelha sob restrição",
"factoryPrices": {
"icms-0": "1303.80",
"icms-12": "1481.59",
"icms-17": "1570.84",
"icms-18": "1590.00",
"icms-19": "1609.63",
"icms-20": "1629.75",
"icms-21": "1650.38",
"icms-22": "1671.54",
"icms-23": "1693.25",
"icms-17.5": "1580.36",
"icms-19.5": "1619.63",
"icms-20.5": "1640.00",
"icms-22.5": "1682.32",
"icms-12-alc": "1463.81",
"icms-17-alc": "1551.99",
"icms-18-alc": "1570.92",
"icms-19-alc": "1590.31",
"icms-20-alc": "1610.19",
"icms-21-alc": "1630.58",
"icms-22-alc": "1651.48",
"icms-23-alc": "1672.93",
"withoutTaxes": "1288.15",
"icms-17.5-alc": "1561.40",
"icms-19.5-alc": "1600.19",
"icms-20.5-alc": "1620.32",
"icms-22.5-alc": "1662.14"
},
"pisCofinsList": "Positiva",
"substanceText": "RISPERIDONA",
"targetSpecies": [],
"consumerPrices": {
"icms-0": "1797.15",
"icms-12": "2042.22",
"icms-17": "2165.24",
"icms-18": "2191.65",
"icms-19": "2218.71",
"icms-20": "2246.44",
"icms-21": "2274.88",
"icms-22": "2304.04",
"icms-23": "2333.97",
"icms-17.5": "2178.36",
"icms-19.5": "2232.49",
"icms-20.5": "2260.57",
"icms-22.5": "2318.90",
"icms-12-alc": "2023.63",
"icms-17-alc": "2145.54",
"icms-18-alc": "2171.70",
"icms-19-alc": "2198.51",
"icms-20-alc": "2225.99",
"icms-21-alc": "2254.18",
"icms-22-alc": "2283.07",
"icms-23-alc": "2312.73",
"withoutTaxes": "1780.80",
"icms-17.5-alc": "2158.54",
"icms-19.5-alc": "2212.17",
"icms-20.5-alc": "2240.00",
"icms-22.5-alc": "2297.81"
},
"invalidBarcodes": [],
"activeSubstances": [
"RISPERIDONA"
],
"therapeuticClass": "N5A1 - ANTIPSICÓTICOS ATÍPICOS",
"commercialisation": {
"year": 2025,
"marketed": true
},
"priceAnalysisNote": null,
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "br.anvisa.cmed-prices"
},
"patientEligibility": "not-assessed",
"registrationNumber": "1123600310400",
"targetSpeciesStatus": "not-reported",
"administrativeStatus": "unknown",
"prescriptionCategory": "prescription-or-restricted",
"prescriptionRequired": true,
"therapeuticClassCode": "N5A1",
"commercialDestination": null,
"registrationNumberFlag": null
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=br" \
--data-urlencode "sourceId=br.anvisa.cmed-prices" \
--data-urlencode "id=br:cmed:presentations:514518050034603"